Author: Brittney Wheeler

The Office of Human Resources will present the Take Care Series, a virtual monthlong wellness experience that will provide short webinar presentations and Q&A sessions. The series kicks off Oct. 4 and runs through Oct. 28.

Researchers at Washington University School of Medicine and the University of Pittsburgh have discovered how Rift Valley fever virus enters cells, pointing the way to new therapies to treat the deadly disease.

Washington University continues its “In St. Louis, for St. Louis” mission by donating 370 study cubbies to nonprofit organizations in the region. Over 1,000 cubbies were ordered at the pandemic’s outset to keep students safe, but only a portion ultimately were needed.

William B. Tolman has been appointed vice dean of research and entrepreneurship in Arts & Sciences, Dean Feng Sheng Hu announced. Tolman is the William Greenleaf Eliot Professor of Chemistry. 

Sophia Hayes, professor of chemistry, has been appointed interim vice dean of graduate education in Arts & Sciences, announced Feng Sheng Hu, dean of the Faculty of Arts & Sciences.

Jeffrey I. Gordon, MD, at Washington University School of Medicine, is a recipient of this year’s Balzan Prize for his role in founding the field of human gut microbiome research and revolutionizing the understanding of gut microbes and their roles in human health and disease.

Washington University School of Medicine will serve as the data and administrative coordinating center for a national effort to investigate how variations in the human genome sequence affect how the genome functions. Such information is critical for understanding human health and diseases.

Washington University was ranked the top employer in Missouri on Forbes 2021 list of “America’s Best Employers.”

A study by researchers at Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System shows that people who have had COVID-19, including those with mild cases, are at an increased risk of developing kidney damage as well as chronic and end-stage kidney diseases.

With a goal of developing rheumatoid arthritis therapies with minimal side effects, School of Medicine researchers have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.